KM Biologics at a Glance

We are proud of our tireless pursuit of providing excellent healthcare for people around the world. Here is a brief outline of how we deliver on our promise.

First in the world

0

products

First Japanese-made

0

products

0

orphan drugs

approved by the Ministry of Health,
Labor and Welfare (Japan)

0

million vials of vaccines

shipped each year

Exciting innovations developed by our

0+

R&D staff

Pandemic influenza vaccines for

0

million people

0+

million newborn babies

screened since 1977

0

new or improved vaccines

in development as of Jun. 2022

*infographic statics as of June, 2022

KM Biologics joined
Meiji Group in 2018
One of the largest food and pharmaceutical companies in Japan